These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 890461)

  • 21. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomifensine antagonizes the ouabain-induced increase in dopamine metabolites in cerebrospinal fluid of the rat.
    Elghozi JL; Le Quan-Bui KH; Devynck MA; Meyer P
    Eur J Pharmacol; 1983 Jun; 90(2-3):279-82. PubMed ID: 6192001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variation of monoamines and their metabolite contents in the cerebrospinal fluid of conscious rats.
    Wada Y; Egashira T; Takayama F; Yamanaka Y; Takada K; Takeda H; Matsumiya T
    Jpn J Pharmacol; 1998 Oct; 78(2):237-40. PubMed ID: 9829629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoamine compounds in cerebrospinal fluid of healthy subjects punctured without preceding strict bed rest: a pilot study.
    Eklundh T; Gunnarsson T; Nordin C
    Neuropsychobiology; 2001 Jan; 43(1):5-10. PubMed ID: 11150891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of dopamine metabolites in CSF and behavioral impairments induced by neonatal hippocampal lesions.
    Wan RQ; Hartman H; Corbett R
    Physiol Behav; 1998 Dec; 65(3):429-36. PubMed ID: 9877408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between central monoaminergic systems: dopamine-serotonin.
    Roccatagliata G; Albano C; Cocito L; Maffini M
    J Neurol Neurosurg Psychiatry; 1979 Dec; 42(12):1159-62. PubMed ID: 160445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid.
    Andersson H; von Essen C; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):129-38. PubMed ID: 4741033
    [No Abstract]   [Full Text] [Related]  

  • 28. Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure.
    Polinsky RJ; Brown RT; Burns RS; Harvey-White J; Kopin IJ
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):914-9. PubMed ID: 2462617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neuroleptic syndrome and central dopamine metabolites.
    Tollefson GD; Garvey MJ
    J Clin Psychopharmacol; 1984 Jun; 4(3):150-3. PubMed ID: 6203936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of neurotransmitter in forensic medicine (report II). A simple and simultaneous analysis of the major monoamine metabolites in human cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.
    Endo T; Nishida A; Kano S
    Nihon Hoigaku Zasshi; 1987 Feb; 41(1):4-9. PubMed ID: 2439728
    [No Abstract]   [Full Text] [Related]  

  • 31. Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology.
    Peters JG
    Eur Neurol; 1979; 18(1):15-8. PubMed ID: 436860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentrations of cerebrospinal fluid monoamine metabolites in suicides.
    Lester D
    Psychol Rep; 1991 Feb; 68(1):146. PubMed ID: 1709746
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapid liquid chromatographic determination of 5-hydroxyindoles and dihydroxyphenylacetic acid in cerebrospinal fluid of the rat.
    Le Quan-Bui KH; Elghozi JL; Devynck MA; Meyer P
    Eur J Pharmacol; 1982 Jul; 81(2):315-20. PubMed ID: 6180913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous determination of DOPAC, MHPG, 5-HIAA and HVA in CSF by direct injection on a liquid chromatograph with coulometric detection.
    d'Eril GV; Rizzo V; Cellerino GP
    Funct Neurol; 1990; 5(2):145-9. PubMed ID: 1699850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of a primate species: effects of ketamine and fluphenazine.
    Bacopoulos NG; Redmond DE; Roth RH
    J Neurochem; 1979 Apr; 32(4):1215-8. PubMed ID: 107277
    [No Abstract]   [Full Text] [Related]  

  • 36. 5-HT(1A) receptor antagonist improves behavior performance of delirium rats through inhibiting PI3K/Akt/mTOR activation-induced NLRP3 activity.
    Qiu Y; Huang X; Huang L; Tang L; Jiang J; Chen L; Li S
    IUBMB Life; 2016 Apr; 68(4):311-9. PubMed ID: 26946964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
    Poceta JS; Parsons L; Engelland S; Kripke DF
    Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reye syndrome: monoamine metabolites in ventricular fluid.
    Shaywitz BA; Venes J; Cohen DJ; Bowers MB
    Neurology; 1979 Apr; 29(4):467-72. PubMed ID: 571546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine and tryptophan derivatives in pig lumbar cerebrospinal fluid. Effects of subchronic administration of dopa associated with benserazide.
    Banting S; Achilli G; Banting A; Le Bars D; Weil-Fugazza J
    Adv Exp Med Biol; 1996; 398():119-21. PubMed ID: 8906253
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic treatment with talipexole dihydrochloride on abnormal involuntary movement in humans.
    Nishikawa T; Yamada S; Tsuda A; Tanaka M; Koga I; Uchida Y
    Clin Neuropharmacol; 1990 Jun; 13(3):259-63. PubMed ID: 1694103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.